| Autor: |
Rambach G; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.; Christian Doppler Laboratory for Invasive Fungal Infections, Innsbruck, Austria., Striednig B; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Neurauter M; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Hermann M; Department of Anesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria., Würzner R; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Lass-Flörl C; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.; Christian Doppler Laboratory for Invasive Fungal Infections, Innsbruck, Austria., Speth C; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.; Christian Doppler Laboratory for Invasive Fungal Infections, Innsbruck, Austria. |
| Abstrakt: |
Platelets are currently thought to harbor antimicrobial functions and might therefore play a crucial role in infections, e.g., those caused by Aspergillus or mucormycetes. The incidence of invasive fungal infections is increasing, particularly during the coronavirus disease 2019 (COVID-19) pandemic, and such infections continue to be life-threatening in immunocompromised patients. For this reason, the interaction of antimycotics with platelets is a key issue to evaluate modern therapeutic regimens. Amphotericin B (AmB) is widely used for the therapy of invasive fungal infections either as deoxycholate (AmB-D) or as a liposomal formulation (L-AmB). We showed that AmB strongly activates platelets within a few minutes. AmB concentrations commonly measured in the blood of patients were sufficient to stimulate platelets, indicating that this effect is highly relevant in vivo . The stimulating effect was corroborated by a broad spectrum of platelet activation parameters, including degranulation, aggregation, budding of microparticles, morphological changes, and enhanced adherence to fungal hyphae. Comparison between the deoxycholate and the liposomal formulation excluded the possibility that the liposomal part of L-Amb is responsible for these effects, as no difference was visible. The induction of platelet activation and alteration by L-AmB resulted in the activation of other parts of innate immunity, such as stimulation of the complement cascade and interaction with granulocytes. These mechanisms might substantially fuel the antifungal immune reaction in invasive mycoses. On the other hand, thrombosis and excessive inflammatory processes might occur via these mechanisms. Furthermore, the viability of L-AmB-activated platelets was consequently decreased, a process that might contribute to thrombocytopenia in patients. |
